Antiviral effect of FIT-039, a selective CDK9 inhibitor, for clinical strains of HSVs

Shinichi Esaki

Presentation information

Oral

[O1-4] DNA 1

Tue. Oct 29, 2019 1:00 PM - 2:00 PM Room 4 (Heian)

Chair：
Shuetsu Fukushi (Department of Virology 1, National Institute of Infectious Diseases)
Masahiro Fujimuro (Department of Cell Biology,Kyoto Pharmaceutical Univsersity)

1:00 PM - 1:15 PM

[O1-4-01] Antiviral effect of FIT-039, a selective CDK9 inhibitor, for clinical strains of HSVs

*Shinichi Esaki^1,2, Fumi Goshima², Gaku Takano^1,2, Toru Daikoku⁴, Takahiro Watanabe², Yoshitaka Sato², Takayuki Murata^2,3, Yukihiro Nishiyama², Hiroshi Kimura² (1. Nagoya City University, 2. Nagoya University, 3. Fujita Health University, 4. Hokuriku University)

Abstract password authentication.
You need a password to access the abstructs of JSV67.
The password is on
your certificate of Participation.

Presentation information

[O1-4] DNA 1

[O1-4-01] Antiviral effect of FIT-039, a selective CDK9 inhibitor, for clinical strains of HSVs

Password